View in EDS PDF Full Text

Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.

Saved in:
Bibliographic Details
Title: Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.
Authors: Mileto SJ; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia., Hutton ML; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia., Walton SL; Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Australia., Das A; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia., Ioannidis LJ; Walter and Eliza Hall Insitiute, Infectious Diseases and Immune Defence Division, Parkville, Australia.; Department of Medical Biology, the University of Melbourne, Parkville, Australia., Ketagoda D; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia., Quinn KM; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.; RMIT University School of Biomedical and Health Sciences, Chronic Inflammatory and Infectious Diseases Program, Bundoora, Australia., Denton KM; Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Australia., Hansen DS; Walter and Eliza Hall Insitiute, Infectious Diseases and Immune Defence Division, Parkville, Australia.; Department of Medical Biology, the University of Melbourne, Parkville, Australia., Lyras D; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.
Source: Gut microbes [Gut Microbes] 2022 Jan-Dec; Vol. 14 (1), pp. 2117504.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101495343 Publication Model: Print Cited Medium: Internet ISSN: 1949-0984 (Electronic) Linking ISSN: 19490976 NLM ISO Abbreviation: Gut Microbes Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36045589
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mileto+SJ%22">Mileto SJ</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Hutton+ML%22">Hutton ML</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Walton+SL%22">Walton SL</searchLink>; Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Das+A%22">Das A</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Ioannidis+LJ%22">Ioannidis LJ</searchLink>; Walter and Eliza Hall Insitiute, Infectious Diseases and Immune Defence Division, Parkville, Australia.; Department of Medical Biology, the University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Ketagoda+D%22">Ketagoda D</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Quinn+KM%22">Quinn KM</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.; RMIT University School of Biomedical and Health Sciences, Chronic Inflammatory and Infectious Diseases Program, Bundoora, Australia.<br /><searchLink fieldCode="AU" term="%22Denton+KM%22">Denton KM</searchLink>; Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Hansen+DS%22">Hansen DS</searchLink>; Walter and Eliza Hall Insitiute, Infectious Diseases and Immune Defence Division, Parkville, Australia.; Department of Medical Biology, the University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Lyras+D%22">Lyras D</searchLink>; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101495343%22">Gut microbes</searchLink> [Gut Microbes] 2022 Jan-Dec; Vol. 14 (1), pp. 2117504.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101495343 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-0984 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219490976%22">19490976 </searchLink><i>NLM ISO Abbreviation: </i>Gut Microbes <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36045589
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/19490976.2022.2117504
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2117504
    Titles:
      – TitleFull: Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mileto SJ
      – PersonEntity:
          Name:
            NameFull: Hutton ML
      – PersonEntity:
          Name:
            NameFull: Walton SL
      – PersonEntity:
          Name:
            NameFull: Das A
      – PersonEntity:
          Name:
            NameFull: Ioannidis LJ
      – PersonEntity:
          Name:
            NameFull: Ketagoda D
      – PersonEntity:
          Name:
            NameFull: Quinn KM
      – PersonEntity:
          Name:
            NameFull: Denton KM
      – PersonEntity:
          Name:
            NameFull: Hansen DS
      – PersonEntity:
          Name:
            NameFull: Lyras D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan-Dec
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1949-0984
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Gut microbes
              Type: main
ResultId 1